Pharmos Cash Flow - Annual (OTCMKTS:PARS)

Add to My Stocks
$0.01 $0 (0%) PARS stock closing price Sep 21, 2018 (Closing)

The Pharmos cash flow statement helps investors understand how well the company is managing its cash flows. The profit-loss statement shows Pharmos profits, the balance sheet shows Pharmos debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. The cash flow statement is essetial while conducting the Pharmos cash flow analysis and can be used to measure the operating performance of Pharmos compared to various industry peers like AOLS stock and TPIY stock. Pharmos saw a outflow of $- from investing activities for 2011.

View details of Pharmos cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2011201020092008
Net Income Cash Flow
-1.97M-1.54M-3.05M-10.08M
Depreciation Depletion Amortization Cash-Flow----
Net Increase (Decrease) in Assets Liabilities--0.24M-0.35M-0.85M
Cash From (used in) Discontinued Operations----
Other Adjustments Net--1.08M-0.12M
Net Cash from (used by) Operating Activities
-1.6M-1.48M-2.28M-10.96M
Increase (Decrease) in Prop Plant And Equipment--0.01M--
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments---3.68M
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
--0.01M-4.21M
Issuance (Purchase) of Equity Shares--1.78M-
Issuance (Repayment) of Debt Securities----
Increase (Decrease) in Bank & Other Borrowings---4M
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities----
Net Cash from (used by) Financing Activities
--1.78M4M
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
-1.6M-1.49M-0.1M-2.75M
Cash & Equivalents at Beginning of Year3.13M4.62M4.73M7.48M
Cash & Equivalents at Year End1.53M3.13M4.62M4.73M
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our BioCryst Pharma financial analysis

Pharmos stock price history provides insight into historical stock price fluctuations, and Pharmos stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Pharmos had a Net Change in Cash and Cash Equivalents of $-1.6M for the latest year 2011. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Pharmos stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Pharmos reported a negative operating cash flow of $-1.6M for 2011 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Pharmos used $- cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for Pharmos.

Key Financial Ratios For Pharmos Cash Flow